Cyclosporine Versus Cyclosporine Plus Mycophenolate Mofetil in Reduced Intensity Allogeneic Stem Cell Transplantation for Intermediate-Risk AML: A Multi-Center Randomized Study from the Acute Leukemia French Intergroup, on Behalf of the Filo, ALFA, and SFGM-TC Study Groups
Authors
Édouard Forcade,
Raynier DevillierJean‐François Hamel,
Jean-Baptiste Méar,
Claude-Éric Bulabois,
Jean-Henri Bourhis,
Sylvain Chantepie,
Pascal Turlure,
Patrice Chevallier,
Patrice Céballos,
Bruno Lioure,
Jacques‐Olivier Bay,
Jean Malfuson,
Stéphanie Nguyen‐Quoc,
Marianne Schwarz,
Jérôme Cornillon,
Michael Loschi,
Mathieu Leclerc,
Marie-Thérèse Rubio,
Étienne Daguindau,
Natacha Maillard,
A Charbonnier,
Nathalie Contentin,
Hélène Labussière‐Wallet,
Alban Villate,
Ibrahim Yakoub‐Agha,
Arnaud Pigneux,
Mathilde Hunault,
Christian Récher,
Hervé Dombret,
Nicole Raus,
Marie Robin,
J Cahn,
Gèrard Socié,
Anne Huynh,
Régis Latour +34 authors
,
Jean‐Baptiste Mear
Tip
Tip